Jasper Therapeutics, Inc.JSPRNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P0
Near historical low
vs 5Y Ago
-0.9x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -18.79% |
| Q2 2025 | 4.16% |
| Q1 2025 | 2.39% |
| Q4 2024 | 1.45% |
| Q3 2024 | 15.69% |
| Q2 2024 | 4.70% |
| Q1 2024 | 15.32% |
| Q4 2023 | -13.82% |
| Q3 2023 | -0.35% |
| Q2 2023 | 9.37% |
| Q1 2023 | -7.23% |
| Q4 2022 | 21.13% |
| Q3 2022 | -3.71% |
| Q2 2022 | -16.60% |
| Q1 2022 | 34.01% |
| Q4 2021 | 18.47% |
| Q3 2021 | -11.37% |
| Q2 2021 | 77.86% |
| Q1 2021 | 39.89% |
| Q4 2020 | -11.90% |
| Q3 2020 | 20.39% |
| Q2 2020 | 61.57% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |